{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T21:39:47Z","timestamp":1781732387279,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,1,30]],"date-time":"2007-01-30T00:00:00Z","timestamp":1170115200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm World Sci"],"published-print":{"date-parts":[[2007,5,23]]},"DOI":"10.1007\/s11096-006-9069-8","type":"journal-article","created":{"date-parts":[[2007,1,29]],"date-time":"2007-01-29T08:05:47Z","timestamp":1170057947000},"page":"190-198","source":"Crossref","is-referenced-by-count":25,"title":["Effect of Fascioliasis on the pharmacokinetic parameters of triclabendazole in human subjects"],"prefix":"10.1007","volume":"29","author":[{"given":"Walid H.","family":"El-Tantawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba F.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmeen A. S.","family":"Mohammed Safwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,1,30]]},"reference":[{"key":"9069_CR1","unstructured":"Laburte C, Mott KE, Hull R, Severne Y. Triclabendazole for fascioliasis: efficacy and tolerability of a single treatment. Infectious diseases and public health. A research and clinical update. In: Angelico M, Rocchi G, editors. Italy: Balaban Publishers; p. 325\u2013333."},{"key":"9069_CR2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1365-2125.1998.00725.x","volume":"45","author":"JB Lecaillon","year":"1998","unstructured":"Lecaillon JB, Godbillon J, Campestrini J, Naquira C, Miranda L, Pacheco R, Mull R Effect of food on the bioavailability of triclabendazole in patients with fascioliasis. Br J Clin Pharmacol 1998; 45:601\u20134.","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"9069_CR3","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1517\/13543784.14.12.1513","volume":"14","author":"J Keiser","year":"2005","unstructured":"Keiser J, Engels D, B\u00fcscher G, Utzinger J Triclabendazole for the treatment of fascioliasis and paragonimiasis. Expert Opin Investig Drugs 2005; 14(12):1513\u201326.","journal-title":"Expert Opin Investig Drugs"},{"key":"9069_CR4","first-page":"333","volume":"21","author":"A El-Shazly","year":"1991","unstructured":"El-Shazly A, El-Desouky I, El-Feky A A case of ectopic fascioliasis in a farmer from Mansoura City. Dakahlia, Egypt. J Egypt Soc Parasitol 1991; 21:333\u20135.","journal-title":"J Egypt Soc Parasitol"},{"issue":"1","key":"9069_CR5","first-page":"317","volume":"32","author":"AN Haseeb","year":"2002","unstructured":"Haseeb AN, El-Shazly AM, Arafa MA, Morsy AT A review on Fascioliasis in Egypt. J Egypt Soc Parasitol 2002; 32(1):317\u201354.","journal-title":"J Egypt Soc Parasitol"},{"key":"9069_CR6","unstructured":"Robert W, Tolan RW Fascioliasis, http:\/\/www.emedicine.com\/ped\/topic760.htm. Cited 14-5-2006"},{"issue":"3","key":"9069_CR7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1079\/JOH2005298","volume":"79","author":"I Fairweather","year":"2005","unstructured":"Fairweather I Triclabendazole: new skills to unravel an old(ish) enigma. J Helminthol 2005; 79(3):227\u201334.","journal-title":"J Helminthol"},{"key":"9069_CR8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF00419183","volume":"20","author":"PK Sanyal","year":"1996","unstructured":"Sanyal PK, Gupta AC The efficacy and pharmacokinetics of long\u2013\u2013term low\u2013\u2013level intraruminal administration of triclabendazole in buffalo with induced fasciolosis. Vet Res Commun 1996; 20:461\u20138.","journal-title":"Vet Res Commun"},{"issue":"8","key":"9069_CR9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-4017(97)00058-7","volume":"76","author":"PK Sanyal","year":"1998","unstructured":"Sanyal PK, Gupta AC The efficacy and pharmacokinetics of long-term low- level intraruminal administration of triclabendazole in urea molasses blocks against induced bovine and bubaline fascioliasis. Vet Parasitol 1998; 76(8):57\u201364.","journal-title":"Vet Parasitol"},{"issue":"1\u20132","key":"9069_CR10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0304-4017(95)00891-8","volume":"63","author":"PK Sanyal","year":"1996","unstructured":"Sanyal PK, Gupta AC The efficacy and pharmacokinetics of triclabendazole in buffalo with induced fasciolosis. Vet Parasitol 1996; 63(1\u20132):75\u201382.","journal-title":"Vet Parasitol"},{"issue":"2","key":"9069_CR11","first-page":"89","volume":"12","author":"PK Sanyal","year":"1998","unstructured":"Sanyal PK Pharmacokinetic behaviour of triclabendazole in domestic Ruminants follows single and divided dose administration. J Vet Parasitol 1998; 12(2):89\u201393.","journal-title":"J Vet Parasitol"},{"key":"9069_CR12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/vr.113.14.315","volume":"113","author":"JC Boray","year":"1983","unstructured":"Boray JC, Crowfoot PD, Strong MB, Allison JR, Schelenbaum M, Von Ornelli M, et al. Treatment of immature and mature Fasciola Hepatica infections in sheep and cattle. Vet Rec 1983; 113:315\u20137.","journal-title":"Vet Rec"},{"key":"9069_CR13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0378-4347(92)80184-R","volume":"576","author":"A Negro","year":"1992","unstructured":"Negro A, Alvarez-Bujidos ML, Ortiz AI, Cubria JC, Menedez R, Ordonez D Reversed\u2013\u2013phase ion\u2013\u2013pair high performance liquid chromatographic determination of triclabendazole metabolites in serum and urine. J Chromatogr 1992; 576:135\u2013141.","journal-title":"J Chromatogr"},{"key":"9069_CR14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4269\/ajtmh.1968.17.382","volume":"17","author":"LK Martin","year":"1968","unstructured":"Martin LK, Beaver PC Evaluation of Kato-Katz thick smear technique for quantitative diagnosis of helminthes infection. Am J Trop Med Hyg 1968; 17:382.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"9069_CR15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2885.1987.tb00078.x","volume":"10","author":"DR Hennessy","year":"1987","unstructured":"Hennessy DR, Lacey E, Steel JW, Prichard RK The kinetics of triclabendazole disposition in sheep. J Vet Pharmacol Ther 1987; 10(1):64\u201372.","journal-title":"J Vet Pharmacol Ther"},{"key":"9069_CR16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0378-4347(00)83301-0","volume":"374","author":"M Alvinerie","year":"1986","unstructured":"Alvinerie M, Galter P Assay of triclabendazole and its main metabolites in plasma by high performance liquid chromatography. J Chromatogr 1986; 374:409\u2013414.","journal-title":"J Chromatogr"},{"issue":"6","key":"9069_CR17","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1081\/AL-120004554","volume":"35","author":"A Abd Elbary","year":"2002","unstructured":"Abd Elbary A, Foda N, El-Gazayerly O, El Khatib M Reversed phase liquid chromatographic determination of vinpocetine in human plasma and its pharmacokinetic application. Anal Letters 2002; 35(6):1041\u201354.","journal-title":"Anal Letters"},{"key":"9069_CR18","first-page":"44","volume-title":"Pharmacology in clinical practice","author":"R Lancaster","year":"1980","unstructured":"Lancaster R 1980 Pharmacology in clinical practice. Butterworth \u2013 Williams Heinenmann Medical books Ltd, London (UK), p. 44. ISBN 0433190523."},{"key":"9069_CR19","first-page":"1","volume":"87","author":"MG Chen","year":"1990","unstructured":"Chen MG, Mott KE Progress in assessment of morbidity due to Fasciola Hepatica infection: a review of recent literature. Trop Dis Bull 1990; 87:1\u201326.","journal-title":"Trop Dis Bull"},{"key":"9069_CR20","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2885.1988.tb00150.x","volume":"11","author":"LDB Kinabo","year":"1988","unstructured":"Kinabo LDB, Bogan JA Pharmacokinetics and efficacy of triclabendazole in goats with induced fasciolosis. J Vet Pharmacol Ther 1988; 11:254\u201359.","journal-title":"J Vet Pharmacol Ther"},{"key":"9069_CR21","first-page":"89","volume":"13","author":"D Yadegari","year":"1999","unstructured":"Yadegari D, Talaie H, Massoud J Clinical trial of triclabendazole on human fascioliasis: long term follow-up. Med J Islam Rep Iran 1999; 13:89\u201391.","journal-title":"Med J Islam Rep Iran"},{"key":"9069_CR22","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/infdis\/154.5.920","volume":"154","author":"Z Farid","year":"1986","unstructured":"Farid Z, Trabbolsi B, Boctor F, Hafez A Unsuccessful use of praziquantel to treat fascioliasis in children. J Infect Dis 1986; 154:920\u2013921.","journal-title":"J Infect Dis"},{"key":"9069_CR23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0035-9203(88)90452-X","volume":"82","author":"Z Farid","year":"1988","unstructured":"Farid Z, Kamal M, Waodly J Treatment of acute toxaemic fascioliasis. Trans R Soc Trop Med Hyg 1988; 82:299.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"9069_CR24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0035-9203(89)90339-8","volume":"83","author":"Farid","year":"1989","unstructured":"Farid Z, Kamal M, Mansour N Praziquantel and Fasciola Hepatica infection. Trans R Soc Trop Med Hyg 1989; 83:813.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"9069_CR25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4269\/ajtmh.1995.52.532","volume":"52","author":"Apt","year":"1995","unstructured":"Apt W, Aguilera X, Vega F, Miranda C, Zulantay I, Perez C, Gabor M, Apt P Treatment of human chronic fasciolosis with triclabendazole: drug efficacy and serologic response. Am J Trop Med Hyg 1995; 52(6):532\u20135.","journal-title":"Am J Trop Med Hyg"}],"container-title":["Pharmacy World & Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-006-9069-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-006-9069-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-006-9069-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T05:51:29Z","timestamp":1559368289000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-006-9069-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,30]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5,23]]}},"alternative-id":["9069"],"URL":"https:\/\/doi.org\/10.1007\/s11096-006-9069-8","relation":{},"ISSN":["0928-1231","1573-739X"],"issn-type":[{"value":"0928-1231","type":"print"},{"value":"1573-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,30]]}}}